null EDQM’s actions to evaluate impact of the detection of an impurity in the active substance paracetamol

EDQM Strasbourg, France 10/07/2020

Following the publication of an article in the Dutch newspaper Nieuwe Rotterdamsche Courant Handelsblad (NRC) concerning an impurity (4-chloroaniline) in the active substance paracetamol manufactured by a specific company which holds a certificate of suitability, the EDQM is actively working with the company and other stakeholders to better understand the potential impact of this impurity and the extent of the issue.